We are live on ! Find out more

Biotechnology
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
CLRB icon
451
Cellectar Biosciences
CLRB
$20.5M
$20.5M $2.57 1.58%
GRDX
452
GridAI Technologies Corp
GRDX
$20.4M
$20.4M $2.90 4.92%
SKYE icon
453
Skye Bioscience
SKYE
$20M
$20M $0.5685 2.03%
TVRD
454
Tvardi Therapeutics
TVRD
$19.7M
$19.7M $2.10 0%
ALLR
455
Allarity Therapeutics
ALLR
$19.3M
$19.3M $1.21 1.63%
MRKR icon
456
Marker Therapeutics
MRKR
$18.8M
$18.8M $1.13 0.89%
NCEL
457
NewcelX Ltd
NCEL
$18.8M
$18.8M $3.49 3.87%
QNTM
458
Quantum Biopharma Class B Subordinate Voting Shares
QNTM
$18.5M
$18.5M $2.89 1.76%
CELU icon
459
Celularity
CELU
$18.4M
$18.4M $0.6353 6.57%
DARE icon
460
Dare Bioscience
DARE
$18.3M
$18.3M $1.22 1.61%
LPCN icon
461
Lipocine
LPCN
$17.5M
$17.5M $2.12 0.47%
HOWL icon
462
Werewolf Therapeutics
HOWL
$17.2M
$17.2M $0.3531 29.4%
NXTC icon
463
NextCure
NXTC
$16.8M
$16.8M $4.14 17.7%
NRSN icon
464
NeuroSense Therapeutics
NRSN
$16.8M
$16.8M $0.4652 2.27%
PLUR icon
465
Pluri
PLUR
$16.7M
$16.7M $1.55 0.64%
CALC icon
466
CalciMedica
CALC
$15.8M
$15.8M $1 19%
OSRH
467
OSR Health
OSRH
$15.7M
$15.7M $0.4480 4.19%
CTXR icon
468
Citius Pharmaceuticals
CTXR
$15.6M
$15.6M $0.5700 9.81%
KTTA icon
469
Pasithea Therapeutics
KTTA
$15.4M
$15.4M $0.4599 3.58%
CYCN icon
470
Cyclerion Therapeutics
CYCN
$14.9M
$14.9M $3.44 1.71%
HIND
471
Vyome Holdings
HIND
$14.9M
$14.9M $2.12 5.47%
PASG icon
472
Passage Bio
PASG
$14.4M
$14.4M $4.47 0.45%
KALA icon
473
KALA BIO
KALA
$14.1M
$14.1M $0.7559 3.59%
AKTX
474
Akari Therapeutics
AKTX
$13.8M
$13.8M $7.86 1.75%
PTN
475
Palatin Technologies
PTN
$13.7M
$13.7M $7.70 1.41%
17 18
19
20 21

Biotechnology Stocks at a Glance

Biotechnology companies research and develop novel drugs and therapies, often with no products yet on the market. Clinical-trial readouts and regulatory decisions drive binary stock moves, making pipeline breadth, cash runway, and partnership deals the key variables.

There are 566 Biotechnology industry stocks tracked by Wall St. Rank, worth a combined $1.2T.

The largest by market cap are Vertex Pharmaceuticals (VRTX) at $121B, Regeneron Pharmaceuticals (REGN) at $78.5B and argenx (ARGX) at $53.4B.

Among institutional investors, Atrium Therapeutics (RNA) drew the most net new fund positions in Q1 2026: 162 funds opened new positions.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q1 2026.